Kahira Pharmaceuticals & Chemical Industries Company (EGX:CPCI)

EGX:CPCI Financials Overview

Financials in millions EGP. Fiscal year is July - June.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Revenue Revenue Growth	2,393	2,079	1,361	1,005	1,112	1,062
Revenue Growth	30.30%	52.80%	35.38%	-9.61%	4.71%	5.11%
Gross Profit Gross Profit Growth	840.33	791.47	517.66	237.3	326.95	268.13
Operating Income Operating Income Growth	627.16	567.86	285.67	76.74	192.08	156.33
Net Income Net Income Growth	504.49	443.72	246.11	97.09	165.74	124.3
Earnings Per Share EPS Growth	33.78	29.71	16.48	6.50	11.10	8.32
EPS Growth	25.16%	80.29%	153.48%	-41.42%	33.34%	13.89%

Revenue by Geography

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023
Egypt Egypt Growth	2,167	1,856	1,254	896.12
Sudan Sudan Growth	32.23	33.98	30.37	19.22
Jordan Jordan Growth	11.72	21.06	13.92	7.44
Yemen Yemen Growth	39.43	42.16	20.39	23.86
Iraq Iraq Growth	31.53	62.93	12.41	34.18
Djibouti Djibouti Growth	-	0.27	0.37	-
Somalia Somalia Growth	16.22	13.51	6.75	9.76
South Sudan South Sudan Growth	-	0.74	0.56	0.45
Mali Mali Growth	-	-	0.79	0.26
Libya Libya Growth	25.58	43.31	12.82	7.23
Nigeria Nigeria Growth	-	0.68	1.4	-
Senegal Senegal Growth	-	-	3.4	1.68
Total Total Growth	2,324	2,075	1,357	1,002

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Investments Cash & Investments Growth	73.64	171.22	168.28	139.38	111.87	146.76
Total Debt Total Debt Growth	168.29	221.78	237.53	164.27	58.36	-
Net Cash (Debt) Net Cash Growth	-94.65	-50.57	-69.25	-24.88	53.52	146.76
Net Cash Growth	-	-	-	-	-63.53%	79.29%
Net Cash Per Share Net Cash Per Share Growth	-6.34	-3.39	-4.64	-1.67	3.58	9.83

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Operating Cash Flow Operating Cash Flow Growth	212.81	378.72	262.89	88.53	51.83	162.25
Capital Expenditures CapEx Growth	-59.12	-139.47	-216.24	-79.07	-17.31	-23.68
Free Cash Flow Free Cash Flow Growth	153.7	239.25	46.65	9.45	34.52	138.57
Free Cash Flow Growth	-41.44%	412.87%	393.48%	-72.61%	-75.09%	-

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Gross Margin	35.12%	38.06%	38.04%	23.61%	29.40%	25.25%
Operating Margin	26.21%	27.31%	20.99%	7.63%	17.27%	14.72%
Pretax Margin	27.04%	27.64%	23.17%	12.69%	19.25%	15.35%
Profit Margin	21.08%	21.34%	18.09%	9.66%	14.90%	11.70%
FCF Margin	6.42%	11.51%	3.43%	0.94%	3.10%	13.05%

Dividends

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 5, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Dividend Per Share Dividend Per Share Growth	16.740	16.740	12.830	5.000	5.000	4.000
Dividend Per Share Growth	30.48%	30.48%	156.60%	0%	25.00%	49.25%
Dividend Yield	3.42%	9.93%	22.95%	15.13%	19.83%	18.00%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 5, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
PE Ratio	14.49	6.03	4.05	6.56	3.33	4.33
Forward PE	-	6.22	6.22	6.22	6.22	6.22
P/FCF Ratio	47.57	11.18	21.38	67.35	15.98	3.89
PS Ratio	3.06	1.29	0.73	0.63	0.50	0.51

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 5, 2026

Data Sources Report a data error